Hieu Nguyen, MD
Family Medicine · Oklahoma City, OKNPI 1053757062
Payments from drug & device makers
What this record shows
AbbVie accounts for 64.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $385 and has fallen 90.5% since, to $36 in 2023.
Across 15 payments — averaging $38.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$369
- Novo Nordisk$60
- Smith+Nephew$36
- Boehringer Ingelheim$33
- Amarin Pharma, Inc.$33
- Amgen$17
- plus $28 from 2 others
Across 12 payments — averaging $19,790 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$190K
- Novartis$47K
What the payments were for
- Travel & lodging$23641%
- Food & beverage$34059%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 2 | $369 |
| Novo Nordisk | 4 | $60 |
| Smith+Nephew | 2 | $36 |
| Boehringer Ingelheim | 2 | $33 |
| Amarin Pharma, Inc. | 2 | $33 |
| Amgen | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Neos Therapeutics, LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$369
How this compares
$576 in reported general payments places this provider in the 55th percentile of 1,730 family medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 11 | $38 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Oklahoma City
- Alexander FrankOklahoma City$3.1M
- Melinda CailOklahoma City$122K
- Jose Maria Borrego AcostaOklahoma City$106K
- John PittmanOklahoma City$39K
- Terrence TruongOklahoma City$32K
- Jonathon KnoxOklahoma City$20K
- Steven SacketOklahoma City$17K
- Stanley CorleyOklahoma City$16K
- Teddy WebbOklahoma City$15K
- Judy MagnussonOklahoma City$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.